[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Abbai R, Mathiyalagan R, Markus J, Kim Y-J, Wang C, Singh P, Ahn S, Farh MEl-Agamy, Yang DChun. Green synthesis of multifunctional silver and gold nanoparticles from the oriental herbal adaptogen: Siberian ginseng. Int J Nanomedicine. 2016;11:3131-3143.
Abboud CN. Granulocyte colony-stimulating factor (G-CSF) Priming Improves Haploidentical Stem Cell Transplantation in High Risk AML subsets: a new role for an old work horse. Biol Blood Marrow Transplant. 2014;20(12):1873-1874.
Abdel-Fatah TMA, Russell R, Albarakati N, Maloney DJ, Dorjsuren D, Rueda OM, Moseley P, Mohan V, Sun H, Abbotts R, et al. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Mol Oncol. 2014.
Abdul MMd, Ibañez DP, Zhao P, Liu H, Zhong X, Li Y, Zhang M, Li W, Li Y, Ward C, et al. Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N). Stem Cell Res. 2019;41:101607.
Abranches E, Spyrou S, Ludwig T. GMP Banking of Human Pluripotent Stem Cells: A US and UK perspective. Stem Cell Res. 2020;45:101805.
Adhami M, MotieGhader H, Haghdoost AAkbar, Afshar RMalekpour, Sadeghi B. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer. Genomics. 2019.
Aerts-Kaya F, Kiliç E, Köse S, Aydin G, Cagnan I, Kuşkonmaz B, Uckan-Cetinkaya D. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells. Cytokine. 2020;139:155407.
Affolter K, Tamm M, Jahn K, Halter J, Passweg J, Hirsch HH, Stolz D. Galactomannan in the Bronchoalveolar Lavage for Diagnosing Invasive Fungal Disease. Am J Respir Crit Care Med. 2014.
Agarwal A, Cooke L, Riley C, Qi W, Mount D, Mahadevan D. Genetic and cytokine changes associated with symptomatic stages of CLL. Leuk Res. 2014.
Aghajani R, Saeidi M, Amiriani T, Marjani M, Amiriani AHossein, Tabib AAkhavan, Marjani A. Genetic polymorphisms -137 (G > C) (rs187238) and -607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran. Arch Physiol Biochem. 2020:1-7.
Agudo J, Ruzo A, Park ESook, Sweeney R, Kana V, Wu M, Zhao Y, Egli D, Merad M, Brown BD. GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions. Nat Biotechnol. 2015.
Ahmed E, Sansac C, Fieldes M, Bergougnoux A, Bourguignon C, Mianné J, Arnould C, Vachier I, Assou S, Bourdin A, et al. Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD). Stem Cell Res. 2018;33:15-19.
Ahmed N, Stenvers KL. Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research. Front Oncol. 2013;3:256.
Aidun A, Firoozabady ASafaei, Moharrami M, Ahmadi A, Haghighipour N, Bonakdar S, Faghihi S. Graphene Oxide Incorporated Polycaprolactone/Chitosan/Collagen Electrospun Scaffold: Enhanced Osteogenic Properties for Bone Tissue Engineering. Artif Organs. 2019.
Akashi K. Guest editorial: leukemia stem cell. Int J Hematol. 2013.
Akdemir KC, Jain AK, Allton K, Aronow B, Xu X, Cooney AJ, Li W, Barton MCraig. Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells. Nucleic Acids Res. 2013.
Al-Abdi S, Al-Aamri M. G6PD deficiency in COVID-19 pandemic: "A ghost in the ghost". Hematol Oncol Stem Cell Ther. 2020.
Al-Jamea L'aH, Woodman A, Heiba NMohamed, Elshazly SA, Ben Khalaf N, Fathallah DM, Al-Nashmi ME, Quiambao JVecina, Deifalla AHalim. Genetic analysis of TMPRSS6 gene in Saudi female patients with iron deficiency anemia. Hematol Oncol Stem Cell Ther. 2020.
Al-Saif AM. Gene therapy of hematological disorders: current challenges. Gene Ther. 2019.
Al-Saud B, Al-Saleem A, Rasheed BAl, Al-Ghonaium A, Al-Ahmari A, Al-Mousa H, Al-Seraihy A, Arnaout R, Al-Jefri A, Elshorbagi S, et al. Graft Versus Host Disease Following HLA-Matched Sibling Donor Compared with Matched Related Donor for Hematopoietic Stem Cell Transplantation for the Treatment of Severe Combined Immunodeficiency Disease. J Clin Immunol. 2019.
Al-Soudy A-S, Nakanishi T, Mizuno S, Hasegawa Y, Shawki HH, Katoh MC, Basha WA, Ibrahim AE, El-Shemy HA, Iseki H, et al. Germline recombination in a novel Cre transgenic line, Prl3b1-cre mouse. Genesis. 2016.
S Alami M, Velard F, Draux F, F Paredes S, Josse J, Lemaire F, Gangloff SC, Graesslin O, Laurent-Maquin D, Kerdjoudj H. Gene screening of Wharton's jelly derived stem cells. Biomed Mater Eng. 2014;24:53-61.
Alapati D, Morrisey EE. Gene Editing and Genetic Lung Disease: Basic Research Meets Therapeutic Application. Am J Respir Cell Mol Biol. 2016.
Alari V, Russo S, Rovina D, Garzo M, Crippa M, Calzari L, Scalera C, Concolino D, Castiglioni E, Giardino D, et al. Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations. Stem Cell Res. 2019;40:101553.
Alari V, Russo S, Rovina D, Gowran A, Garzo M, Crippa M, Mazzanti L, Scalera C, Prosperi E, Giardino D, et al. Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*). Stem Cell Res. 2018;30:175-179.